newsfilter
← Latest News
PR Newswire·

BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program

Pan-Sarbecovirus Vaccines Identified by WHO as a Critical Need VANCOUVER, BC, June 3, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") announced today that The Ohio State University ("Ohio